Maynard Um
-
-
-
-
-
-
-
Goldman Sachs on Viking Therapeutic (VKTX): 'we believe these results look encouraging'
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Viking Therapeutic (VKTX)
-
-
-
-
-
-
-
Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'
-
-
-
-
-
-
-
Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)
-
-
-
-
-
-
-
Viking Therapeutics presents VK2735 obesity data at ObesityWeek 2025
-
-
-
-
-
-
-
Viking Therapeutics begins VK2735 maintenance dosing trial for obesity
-
-
-
-
-
-
-
Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)
-
468,589 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


